FDA OKs Oralair, First US Sublingual Allergy Immunotherapy

FDA OKs Oralair, First US Sublingual Allergy Immunotherapy:

"The US Food and Drug Administration (FDA) has approved Oralair (Stallergenes, Inc), the first sublingual immunotherapy in the United States to treat multiple grass pollens.

The drug is indicated for the treatment of persons aged 10 to 65 years with grass pollen–induced allergic rhinitis with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific immunoglobulin E antibodies for any of five grass species: sweet vernal, orchard, perennial rye, timothy, and Kentucky blue grass."


Prevention is the best medicine when faced w/ allergy issues.

Helpful tactics I Rx in my chiropractic clinic:

Implementing the deflame diet to reduce inflammation in the body overall.

Saline lavage the sinuses 3 times per day.

Air purifier in the bedroom.

Use of air filters for reducing allergens in the home

If you exercise outdoors then choose the time of day w/ lowest pollen count.

Shower post outdoor activities to remove pollen.




'via Blog this'